What companies are VIR's competitors?

Vir Biotechnology, Inc. (VIR)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does VIR compare to its peers?

The peer comparison table on this page shows Vir Biotechnology, Inc. (VIR) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does VIR operate in?

Vir Biotechnology, Inc. (VIR) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

VIR

Vir Biotechnology, Inc.

NASDAQ·Biotechnology · Healthcare

$10.57$0.14+1.34%

Market cap$1.79B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About VIR

What companies are VIR's competitors?: Vir Biotechnology, Inc. (VIR)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does VIR compare to its peers?: The peer comparison table on this page shows Vir Biotechnology, Inc. (VIR) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does VIR operate in?: Vir Biotechnology, Inc. (VIR) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

VIR

Vir Biotechnology, Inc.

NASDAQ·Biotechnology · Healthcare

$10.57$0.14+1.34%

Market cap$1.79B·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


MRNAMRNAModerna, Inc.	Moderna, Inc.	$200.10	$79.9B
BNTXBNTXBioNTech SE	BioNTech SE	$88.12	$22.1B
BCRXBCRXBioCryst Pharmaceuticals, Inc.	BioCryst Pharmaceuticals, Inc.	$7.65	$2.0B
NVAXNVAXNovavax, Inc.	Novavax, Inc.	$9.70	$1.6B
ABUSABUSArbutus Biopharma Corp	Arbutus Biopharma Corp	$4.20	$832.0M
VALNVALNValneva SE	Valneva SE	$5.26	$494.8M
ASMBASMBAssembly Biosciences, Inc.	Assembly Biosciences, Inc.	$19.84	$404.0M
ENTAENTAEnanta Pharmaceuticals, Inc.	Enanta Pharmaceuticals, Inc.	$11.64	$339.0M
AVIRAVIRAtea Pharmaceuticals, Inc.	Atea Pharmaceuticals, Inc.	$4.04	$324.0M
COCPCOCPCocrystal Pharma, Inc.	Cocrystal Pharma, Inc.	$0.95	$18.3M

Frequently Asked Questions About VIR

What companies are VIR's competitors?: Vir Biotechnology, Inc. (VIR)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does VIR compare to its peers?: The peer comparison table on this page shows Vir Biotechnology, Inc. (VIR) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does VIR operate in?: Vir Biotechnology, Inc. (VIR) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.